GlaxoSmithKline has revealed it is working to integrate Apple's ResearchKit into its clinical trials, setting it up to be one of the first drug developers to adopt the recently introduced platform. The Big Pharma sees the open-source research app as a useful tool for data collection.
A team at the University of California, San Diego (UCSD), has found biomarkers for ovarian tumors by mining two National Institutes of Health-sponsored databases. The bioinformatics-enabled research program has raised expectations that earlier diagnoses of ovarian cancer can be made, an advance that could improve outcomes in a tough therapeutic indication.
Medidata has connected its Clinical Cloud to Apple's ResearchKit. The link means researchers can feed data gathered by ResearchKit apps into Medidata's cloud platform, where the information can be integrated with other sources of clinical trial results.
Legislation that would mandate the creation of a system to share de-identified clinical trial data has moved a step closer to coming into force. The text is included in the latest draft of the 21st Century Cures Act, which is almost 200 pages shorter than the original proposal.
Eli Lilly, Novartis and Pfizer have found a new home for the tech they created to improve ClinicalTrials.gov. The group is giving what it has achieved to date to TrialReach, a tech company developing a patient-focused clinical trial discovery platform.
The World Health Organization has updated its position on the disclosure of clinical trial data. Having advocated greater use of registries back in 2005, WHO now wants to see the establishment of a more integrated IT system that includes data from new and old clinical trials.
Peking University Clinical Research Institute is trying to drag China into the eClinical era by expanding its alliance with Medidata. Under the terms of the revised relationship, the partners will help local drug developers access electronic data capture tools and other eClinical technologies.
Celgene and Genentech are funding a clinical trial innovation prize focused on doubling the rate of participation in studies of cancer drugs. The project is challenging the crowd to submit ideas and evidence of their effectiveness in return for the chance to land a piece of the $75,000 prize kitty.
AstraZeneca is extending its use of Elixir Software's R&D workflow-management software, in part to support communication while it is moving its focal point in the United Kingdom from Alderley Park to Cambridge.
A Sanofi-backed consortium has won clearance to run a virtual diabetes trial in Europe. The regulatory nod reportedly marks the first time European authorities have green-lit a clinical trial with full electronic informed consent.